|
2017 |
Nrf2 signaling increases expression of ATP-binding cassette subfamily C mRNA transcripts at the blood-brain barrier following hypoxia-reoxygenation stress. |
Patrick T Ronaldson, PhD, FAAPS |
|
2017 |
Open-Label Allopregnanolone Treatment of Men with Fragile X-Associated Tremor/Ataxia Syndrome. |
Roberta Diaz Brinton, Ph.D |
|
2017 |
Remote Ischemic Conditioning Preserves Cognition and Motor Coordination in a Mouse Model of Traumatic Brain Injury. |
Tally Largent-Milnes, PhD, Todd Vanderah, PhD |
|
2017 |
TGF-β triggers rapid fibrillogenesis via a novel TβRII-dependent fibronectin-trafficking mechanism. |
Nam Lee, Ph.D. |
|
2017 |
Long-lasting antinociceptive effects of green light in acute and chronic pain in rats. |
Mohab M. Ibrahim, PhD, MD, Tally Largent-Milnes, PhD, T. Philip Malan, PhD, MD, Frank Porreca, PhD, Todd Vanderah, PhD |
|
2017 |
16S rRNA gene sequencing on a benchtop sequencer: accuracy for identification of clinically important bacteria. |
|
|
2017 |
Sonogashira diversification of unprotected halotryptophans, halotryptophan containing tripeptides; and generation of a new to nature bromo-natural product and its diversification in water |
Christopher Cartmell |
|
2017 |
Recent Advances in the Realm of Allosteric Modulators for Opioid Receptors for Future Therapeutics. |
Frank Porreca, PhD |
|
2017 |
Novel Molecular Strategies and Targets for Opioid Drug Discovery for the Treatment of Chronic Pain. |
John M. Streicher, PhD |
|
2017 |
Editorial: The Metabolic-Inflammatory Axis in Brain Aging and Neurodegeneration. |
Roberta Diaz Brinton, Ph.D, Fei Yin, Ph.D. |
|
2017 |
Targeting the S1P/S1PR1 axis mitigates cancer-induced bone pain and neuroinflammation. |
Tally Largent-Milnes, PhD, Todd Vanderah, PhD |
|
2017 |
Hypoxic Stress and Inflammatory Pain Disrupt Blood-Brain Barrier Tight Junctions: Implications for Drug Delivery to the Central Nervous System. |
Thomas P Davis, PhD, Jeffrey J. Lochhead, PhD, Patrick T Ronaldson, PhD, FAAPS |
|
2017 |
Anti-NMDA receptor encephalitis presenting as a primary psychotic disorder. |
Jeffrey J. Lochhead, PhD |
|
2017 |
Synthetic analogues of cyanobacterial alkaloid cylindrospermopsin and their toxicological activity. |
Christopher Cartmell |
|
2017 |
Homology-guided mutational analysis reveals the functional requirements for antinociceptive specificity of collapsin response mediator protein 2-derived peptides. |
Todd Vanderah, PhD |
|
2017 |
Kappa opioid receptor antagonists: A possible new class of therapeutics for migraine prevention. |
John M. Streicher, PhD |
|
2017 |
Sex differences in Alzheimer risk: Brain imaging of endocrine vs chronologic aging. |
Roberta Diaz Brinton, Ph.D |
|
2017 |
Functional Expression of P-glycoprotein and Organic Anion Transporting Polypeptides at the Blood-Brain Barrier: Understanding Transport Mechanisms for Improved CNS Drug Delivery? |
Thomas P Davis, PhD, Patrick T Ronaldson, PhD, FAAPS |
|
2018 |
A Kappa Opioid Receptor Agonist Blocks Bone Cancer Pain Without Altering Bone Loss, Tumor Size, or Cancer Cell Proliferation in a Mouse Model of Cancer-Induced Bone Pain. |
Tally Largent-Milnes, PhD, John M. Streicher, PhD, Todd Vanderah, PhD |
|
2018 |
Loss of Blood-Brain Barrier Integrity in a KCl-Induced Model of Episodic Headache Enhances CNS Drug Delivery. |
Thomas P Davis, PhD, Erika Liktor-Busa, PhD, PharmD, Tally Largent-Milnes, PhD, Todd Vanderah, PhD |
|
2018 |
Peripherally restricted cannabinoid 1 receptor agonist as a novel analgesic in cancer-induced bone pain. |
Mohab M. Ibrahim, PhD, MD, Tally Largent-Milnes, PhD, Todd Vanderah, PhD |
|
2018 |
Blood-brain barrier dysfunction in ischemic stroke: targeting tight junctions and transporters for vascular protection. |
Patrick T Ronaldson, PhD, FAAPS |
|
2018 |
Continuous remote ischemic conditioning attenuates cognitive and motor deficits from moderate traumatic brain injury. |
Tally Largent-Milnes, PhD, Todd Vanderah, PhD |
|
2019 |
Animal Models for the Study of Bone-Derived Pain. |
Tally Largent-Milnes, PhD, Todd Vanderah, PhD |
|
2019 |
A Novel Angiotensin-(1-7) Glycosylated Mas Receptor Agonist for Treating Vascular Cognitive Impairment and Inflammation-Related Memory Dysfunction. |
Tally Largent-Milnes, PhD, Kathleen Rodgers, Ph.D., Todd Vanderah, PhD |
